DOSSIER · UPDATED 18 NOV 2025

Sonoma Biotherapeutics

Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing…

sonomabio.com ↗Claim this profile
Founded
2020
Headcount
94
Open roles
0
Last raised
Grant · $300K
SECTION I · THE BRIEF

Inside Sonoma Biotherapeutics

Brief #87583Updated 18 NOV 2025SOUTH SAN FRANCISCOGVGRANT
Employbl Dossier

Sonoma Biotherapeutics

Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is…

Founded
2020
Headcount
94
Open roles
0
Last raised
Grant · $300K
Section II — RestrictedMembers only
  • Engineering interview process at Sonoma Biotherapeutics
  • Tech stack & infrastructure choices
  • Culture & day-to-day work style
  • Why join now vs. 6 months from now
  • Hiring focus & open headcount by team
  • Comp philosophy and band context
Open Sonoma Biotherapeutics briefSign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Alexander RudenskyAlexander Rudensky
Fred RamsdellFred Ramsdell
OPEN ROLES

Hiring at Sonoma Biotherapeutics

Current Job Listings

Listing 0 of 0 job openings
We don't currently have any jobs listed for this company. We suggest visiting the Jobs Search page if you are looking for exciting new tech and startup opportunities.
FUNDING

Capital raised

Total Amount Raised: $365,000,000

Sonoma Biotherapeutics' Investors

Sonoma Biotherapeutics Funding Rounds

  • Grant

    $300,000

  • Corporate Round

    $30,000,000

  • Corporate Round

    $30,000,000

    Corporate Round Investors

    Regeneron Pharmaceuticals

  • Series B

    $265,000,000

  • Series B

    $265,000,000

    Series B Investors

    Ally Bridge Group
    Fidelity
    NS Investment
    JDRF T1D Fund
    Lilly Asia Ventures
    ArrowMark Colorado Holdings
    8VC
    Vertex Ventures HC
    Casdin Capital
    GV
    Avidity Partners
    Lifeforce Capital
    Arch Venture Partners
    Janus Capital
    Alexandria Venture Investments
    Mirae Asset
    Deep Track Capital
    Osage University Partners II
    Frazier Management
    Octagon Capital Advisors

  • Series A

    $30,000,000

  • Series A

    $30,000,000

    Series A Investors

    Arch Venture Partners
    8VC
    Lilly Asia Ventures
    Lyell Immunopharma
    JDRF T1D Fund
    Alexandria Venture Investments
    Lifeforce Capital
    Octagon Capital Advisors

  • Series A

    $40,000,000

  • Series A

    $40,000,000

    Series A Investors

    Lyell Immunopharma
    8VC
    Milky Way Ventures
    Arch Venture Partners
Funding info provided by Diffbot.
TAGS

Categorized in

Company Collections

These are collections Sonoma Biotherapeutics is a part of. Click on the collection name to view similar companies.

Sonoma Biotherapeutics' Investors

Sonoma Biotherapeutics' Industries

Company Collections For Sonoma Biotherapeutics

LOCATIONS

Where they work

Sonoma Biotherapeutics Headquarters Location

400 E Jamie Ct suite 202, South San Francisco, CA, 94080

Loading map…